NCT07145242

Brief Summary

The goal of this clinical trial is to learn about the short-term effects of acupuncture on migraine-related pain, postural balance, and quality of life in women with migraine. The main questions it aims to answer are: Does acupuncture reduce migraine pain intensity? Does acupuncture improve balance and postural stability in women with migraine? Does acupuncture improve quality of life in women with migraine? This study does not include a comparison group. Participants will: Receive six standardized acupuncture sessions over two weeks (three sessions per week). Complete questionnaires on pain intensity (Visual Analogue Scale, VAS) and quality of life (SF-36). Undergo stabilometric balance testing before and after the acupuncture program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

August 19, 2025

Last Update Submit

August 27, 2025

Conditions

Keywords

acupuncture, migraine, medicine, balance, quality of life, pain mgmt, stress

Outcome Measures

Primary Outcomes (1)

  • Change in migraine pain intensity measured by Visual Analogue Scale (VAS)

    Migraine pain intensity will be assessed using a 10 cm Visual Analogue Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain." The primary outcome is the change in mean VAS score from baseline to 2 weeks post-intervention.

    Baseline (Day 1) and at 2 weeks (end of intervention).

Secondary Outcomes (2)

  • Change in quality of life measured by SF-36

    Baseline (Day 1) and at 2 weeks (end of intervention)

  • Change in postural balance measured by stabilometric platform

    Baseline (Day 1) and at 2 weeks (end of intervention)

Study Arms (1)

Short-Term Acupuncture for Migraine

EXPERIMENTAL

Participants in this arm received short-term acupuncture treatment specifically targeted for migraine accompanied by dizziness. The intervention consisted of six acupuncture sessions administered over a two-week period by a licensed acupuncturist. Standardized acupoints (GB7, GB14, GB20, GV20, LI4, LR3, Yintang) were used, with sterile disposable needles inserted according to traditional Chinese medicine guidelines. Each session lasted approximately 30 minutes. No comparator group was included, as this was a pilot exploratory trial.

Other: Acupuncture

Interventions

Intervention Description \* § Add details that will distinguish this intervention from other interventions in this or another clinical study.

Short-Term Acupuncture for Migraine

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult women (≥18 years)
  • Neurologist-confirmed diagnosis of migraine according to the International Classification of Headache Disorders (ICHD-3)
  • Presence of migraine-related symptoms, including recurrent headaches with or without aura
  • Ability and willingness to provide written informed consent

You may not qualify if:

  • Pregnancy
  • Presence of other significant neurological or vestibular disorders
  • Severe comorbidities that could interfere with balance assessment
  • Contraindications for acupuncture treatment (e.g., skin infections at needling sites, bleeding disorders)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klaipeda university

Klaipėda, Klaipėda County, Lithuania

Location

MeSH Terms

Conditions

Migraine Disorders

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Laura Zaliene, PhD

    Klaipėda University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer, Klaipėda University

Study Record Dates

First Submitted

August 19, 2025

First Posted

August 28, 2025

Study Start

July 1, 2024

Primary Completion

December 30, 2024

Study Completion

December 31, 2024

Last Updated

August 28, 2025

Record last verified: 2025-08

Locations